The invention relates to a device for recording the parameters of an aerosol, in particular in inhalation therapy devices.
Known from DE 100 22 795 A is a breath-controlled inhalation therapy device, in which an infrared light transmitter is disposed adjacent to an infrared light receiver in an opening in the mouthpiece of the therapy device such that the infrared light emitted by the transmitter arrives in a detection area in which a still aerosol is located. The infrared light is reflected by the aerosol particles or droplets and arrives at the receiver which emits an output signal that corresponds to the density of the aerosol. The transparent surface through which the infrared light is emitted and the reflected infrared light is received is disposed in the interior of the therapy device, i.e., for example, in the internal space of the mouthpiece, so that in the known inhalation therapy device, the light shining in can directly arrive at the aerosol droplets from the transmitter and the light reflected by these droplets can arrive at the receiver. The transmitter and receiver work with optical-imaging radiation.
Although the known device is basically suitable for ensuring breath-controlled nebulisation, and although the control method described in DE 100 22 795 A can be reliably realised, it has shown that owing to the adhesion of larger and smaller droplets to the transparent surface through which the light passes, the analysis of the output signal of the receiver during the control process is comparatively complicated, in particular if the precision desired for therapeutic applications is supposed to be achieved.
There is therefore demand for an inhalation therapy device in which detection of aerosol particles or droplets in a given spatial area in the therapy device occurs in a manner that allows an analysis, in particular control of nebulisation, to be designed more simply and thus more economically.
In view of the above, it is the object of the invention to specify a device for recording the parameters of an aerosol and, in particular, an inhalation therapy device having such a device, in which the analysis of detection signals and the control of nebulisation based thereon is simplified.
This aim is achieved by means of a device having the features described in patent claim 1. Advantageous embodiments can be seen in the sub-claims.
It is an important factor of the invention that shining in, for example of light into the detection area, occurs through a translucent material and not through a transparent material. The beam expansion linked therewith leads to a surprisingly high insensitivity to aerosol particles or droplets that adhere to the material through which shining occurs, without the analysability of the measurement signals being affected. This considerable insensitivity to impaction is based on an averaging over large spatial areas that is linked with the beam expansion. According to the invention, the transmitter and receiver work with non-imaging radiation.
If shining in occurs in a clocked manner or intermittently, the effect of ambient light can be determined using a reference measurement in the dark phases and can be later consulted when analysing the measurement signals in the light phases. The reaction speed of detection is thereby determined by means of the clock frequency.
Since at least two receivers are provided according to the invention, the output signals of the receivers could be mathematically linked in the analysis, for example by forming a quotient, whereby reducing the effect of ambient light and/or temperature fluctuations. It is advantageous in this regard for one receiver to be disposed in the main beam direction of the transmitter and for the other to be disposed substantially perpendicularly to the main beam direction.
Reduction of the effect of ambient light can also occur by means of series-connected long-pass filters, preferably on the receivers.
In the following description of embodiments, the invention is explained in more detail by means of the figures.
A general view of an embodiment of an inhalation therapy device according to the invention is shown in
Alternatively, an inhalation therapy device having a membrane nebuliser 52 can also be used instead of the inhalation therapy device with a nebuliser nozzle; such an inhalation therapy device is exemplified in
As shown in
The transmitting means 7 emits light, preferably infrared light (or another suitable radiation), into the interior of the mouthpiece 5, namely into the aerosol resting area. The first receiving means 8 receives the proportion of light that penetrates the mouthpiece 5 essentially unscattered and releases a first output signal IT which is supplied to an analysis/control unit 10. The first receiving means 8 is arranged, for example, in the main beam direction of the transmitting means 7. The second receiving means 9 receives the proportion of light that is scattered by aerosol particles or droplets and releases a second output signal IS which is also supplied to the analysis/control means 10. The second receiving means 9 is arranged, for example, at an angle, preferably perpendicularly to the main beam direction of the transmitting means 7.
A cross-section through the mouthpiece 5 of the embodiment of an inhalation therapy device according to the invention as seen in
It can be seen in
It can furthermore be seen in
It is less important for the arrangement of the first receiving means 8 on the mouthpiece 5 whether the mouthpiece is produced from a transparent or translucent material. However, the light preferably falls through a translucent material into the first receiving means 8. Reference is made in this regard to the explanations regarding the transmitting means 7 and the first wall section 13, which accordingly also apply to the first receiving means 8 and the second wall section 14. Particularly economical is again a mouthpiece 5 that is made of a translucent material, which renders a further translucent material on the first receiving means 8 unnecessary.
Finally, it can be seen in
It is less important for the arrangement of the second receiving means 9 on the mouthpiece 5 whether the mouthpiece is produced from a transparent or translucent material. However, the light preferably falls through a translucent material into the second receiving means 9. Reference is made in this regard to the explanations regarding the transmitting means 7 and the first wall section 13, which accordingly also apply to the second receiving means 9 and the second wall section 15. Particularly economical is again a mouthpiece 5 that is made of a translucent material, which renders a further translucent material on the second receiving means 9 unnecessary.
The first and second output signals (ITL, ISL) of the receiving means 8 and 9 are supplied to the control means 10, which analyses the first and second output signals (ITL, ISL) to determine the parameters of an aerosol in the aerosol resting area A.
A first analysis can occur to the effect that the control means 10 determines whether or not an aerosol is present in the aerosol resting area A. A high first output signal ITL and a low second output signal ISL indicate that almost no aerosol is present in the aerosol resting area A. A low first output signal ITL and a high second output signal ISL indicate that an aerosol is present in the aerosol resting area A. Therefore, the presence of the aerosol in the aerosol resting area A can be determined as a first parameter of said aerosol.
If the second output signal ISL increases and the first output signal ITL decreases, this indicates that an aerosol is present in the aerosol resting area A whose density is increasing. If the first output signal ITL increases and the second output signal ISL decreases, this indicates that an aerosol is present in the aerosol resting area A whose density is decreasing. Therefore, the change in the density of the aerosol in the aerosol resting area A can be determined as a second parameter of said aerosol.
If calibration is carried out, the aerosol density is also to be absolutely determined as a third parameter from the output signals ISL and ISL.
The control method described in DE 100 22 795 A can essentially also be carried out based on the two output signals ISL and ISL. Particularly suitable in this regard is an inhalation therapy device having a membrane nebuliser, as shown, for example, in
For this purpose, the quotient
QA=ISL/ITL
is preferably formed from the first and second output signals ISL and ISL in the control means 10. The effect of ambient light and temperature fluctuations on the transmitting and receiving means 7, 8 and 9 is thereby eliminated, or is at least clearly reduced.
For example, the presence of aerosol in the aerosol resting area A defined by the transmitting and receiving means can be determined in that the control means 10 determines whether the quotient is above a threshold QAmin, which is only exceeded if a sufficient amount of aerosol particles or droplets are present in the mouthpiece 5 between the transmitter 7 and the receivers 8, 9.
To further improve insensitivity to ambient light, the transmitting means 7 is intermittently operated by the control means 10 such that first time periods Z1, in which the transmitting means 7 emits light into the aerosol resting area A, alternate with second time periods Z2, in which the transmitter means 7 does not emit any light. The output signals of the first and second receiving means 8 and 9 are different in both time periods.
In one of the second time periods Z2, in which no light is emitted into the aerosol resting area A by the transmitting means 7, only ambient light reaches the first and second receiving means 8 and 9, which shines, for example, through the translucent material of the mouthpiece 5 or the mouthpiece opening into the aerosol resting area A and arrives at the first or second receiving means 8 and 9. In one of the first time periods Z1, in which the transmitting means 7 emits light into the aerosol resting area A, transmission light TL and scattered light SL in addition to ambient light also reach the first and second receiving means 8 and 9. The output signal of the first and second receiving means 8 and 9 thus changes at least as regards how high it is. The output signals ITL and ISL in the time periods Z1 and Z2 can be detected by the control means 10 and can be allocated to time periods Z1 and Z2 since the control means 10 determines the sequence of the time periods via activation of the transmitting means 7.
When the transmitting means 7 is operated intermittently, it is possible to determine, in the second time periods Z2 in which the transmitting means 7 does not emit any light into the aerosol resting area A, the proportion of ambient light contained in the output signal of the first and second receiving means 8 and 9. The output signals ITLU and ISLU occurring in the second time periods Z2 are attributed to the ambient light that reaches the receivers. The control means 10 takes into account the proportions of the output signals ITLU and ISLU attributed to the ambient light in the first time periods Z1, in which the transmitting means 7 emits light into the aerosol resting area A, in order to eliminate the proportion of ambient light in the output signals ITL and ISL, for example in a manner in which the differences (ITL−ITLU) and (ISL−ISLU) are formed. The effect of ambient light is further reduced in this manner. In this case,
is formed as the quotient. It is thereby ensured, owing to the repeated succession of the first and second time periods Z1 and Z2, that fluctuations in ambient light are also taken into consideration.
The intermittent operation of the transmitting means 7 furthermore makes it possible to check the operability of the transmitting means 7 and the receiving means 8 and 9 since alternating the operating state of the transmitting means 7 must lead to a change in the output signal of the receiving means. If there is no change, a defect in the transmitter or in one of the receivers can be concluded.
Number | Date | Country | Kind |
---|---|---|---|
102 26 334.5 | Jun 2002 | DE | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP03/05998 | 6/6/2003 | WO | 11/4/2005 |